CytomX Therapeutics, Inc.·4

Mar 2, 11:54 AM ET

GLUCK FREDERICK W 4

4 · CytomX Therapeutics, Inc. · Filed Mar 2, 2018

Insider Transaction Report

Form 4
Period: 2018-02-28
Transactions
  • Sale

    Common Stock

    2018-02-28$30.00/sh3,819$114,570292,824 total(indirect: By Trust)
Holdings
  • Common Stock

    (indirect: By LLC)
    22,111
  • Common Stock

    (indirect: By Spouse)
    3,200
Footnotes (3)
  • [F1]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
  • [F2]The Reporting Person is a trustee of Frederick W. Gluck 1997 Family Trust dtd July 28, 1997.
  • [F3]Richlin Partners, LLC is an entity owned of record by the spouse of the Reporting Person.

Documents

2 files